ANI Pharmaceuticals (ANIP) had the highest return between 2013 and 2016 by a US stock in the Pharmaceuticals Industry, returning 708.3%.

ASSET	YEARS	% RETURN
ANI Pharmaceuticals (ANIP)	2013-2016	708.27%
Cronos (CRON)	2013-2016	564.34%
Corcept Therapeutics (CORT)	2013-2016	377.63%
Aurora Cannabis (ACB)	2013-2016	278.87%
Avadel Pharmaceuticals (AVDL)	2013-2016	247.49%
Supernus Pharmaceuticals (SUPN)	2013-2016	241.68%
Assertio Therapeutics (ASRT)	2013-2016	185.58%
Canopy Growth (CGC)	2013-2016	178.59%
Amphastar P (AMPH)	2013-2016	163.14%
Prestige Brand (PBH)	2013-2016	155.74%
Aclaris Therapeutics (ACRS)	2013-2016	127.3%
Theravance Biopharma (TBPH)	2013-2016	116.14%
CorMedix (CRMD)	2013-2016	106.73%
KING PHARMACEUTICALS (KG)	2013-2016	101.97%
Jazz Pharmaceuticals (JAZZ)	2013-2016	100.68%
Bristol-Myers Squibb (BMY)	2013-2016	96.55%
Phibro Animal Health (PAHC)	2013-2016	84.14%
TherapeuticsMD (TXMD)	2013-2016	83.17%
Johnson & Johnson (JNJ)	2013-2016	81.87%
Pacira BioSciences (PCRX)	2013-2016	81.87%
Omeros (OMER)	2013-2016	80.69%
Zoetis (ZTS)	2013-2016	75.22%
Eli Lilly and (LLY)	2013-2016	66.41%
Oramed Pharmaceuticals (ORMP)	2013-2016	64.52%
Nektar Therapeutics (NKTR)	2013-2016	61.66%